# Johnson & Johnson (JNJ) — Q4-2024 Earnings Results

**Report date:** 2025-01-22 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down 1.94%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.04 | N/A | +1.85% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a cautious optimism about future growth. They are focused on operational efficiency and innovation to drive performance.

**Key quotes:**

> Management highlighted ongoing efforts to streamline operations.

> They noted a focus on innovation in their product lines.

> There was an emphasis on maintaining strong market positions despite challenges.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Johnson & Johnson's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by nearly 2% following the announcement, likely due to the lack of revenue data and guidance. Investors may be cautious as the company navigates ongoing market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2024_